Education
About Us
Working with TipRanks
Follow Us
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 63.72M | $ 58.44M | $ 51.49M | $ 43.52M | $ 17.40M |
| Gross Profit | $ 58.10M | $ 53.16M | $ 46.95M | $ 39.12M | $ 15.32M |
| Operating Income | $ -171.78M | $ -82.38M | $ -78.65M | $ -78.04M | $ -62.85M |
| EBITDA | $ -176.14M | $ -66.42M | $ -61.91M | $ 2.54M | $ -146.09M |
| Net Income | $ -193.51M | $ -80.74M | $ -71.04M | $ -6.55M | $ -155.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 392.10M | $ 195.81M | $ 102.30M | $ 164.16M | $ 228.06M |
| Total Assets | $ 457.94M | $ 252.06M | $ 149.29M | $ 204.89M | $ 261.86M |
| Total Debt | $ 75.78M | $ 83.39M | $ 64.28M | $ 58.98M | $ 58.44M |
| Net Debt | $ -316.32M | $ -112.42M | $ -38.02M | $ -105.18M | $ -169.62M |
| Total Liabilities | $ 142.59M | $ 160.93M | $ 113.91M | $ 116.89M | $ 185.77M |
| Stockholders' Equity | $ 315.34M | $ 91.13M | $ 35.38M | $ 88.00M | $ 76.09M |
| Cash Flow | |||||
| Free Cash Flow | $ -135.97M | $ -76.32M | $ -63.32M | $ -66.74M | $ -54.40M |
| Operating Cash Flow | $ -134.68M | $ -70.23M | $ -59.60M | $ -65.55M | $ -53.55M |
| Investing Cash Flow | $ -1.29M | $ -6.09M | $ -3.71M | $ -1.19M | $ -841.00K |
| Financing Cash Flow | $ 332.11M | $ 169.83M | $ 1.45M | $ 2.85M | $ 228.01M |